Are there etiology-specific risk factors for adverse outcomes in patients on Impella 5.5 support?Central MessagePerspective 由 Jean-Luc A. Maigrot, BS, Lucy Thuita, MS, Michael Z.Y. Tong, MD, MBA, Edward G. Soltesz, MD, MPH, Nicholas G. Smedira, MD, MBA, Shinya Unai, MD, Randall C. Starling, MD, MPH, Andrew Higgins, MD, David Moros, MD, Eugene H. Blackstone, MD, Aaron J. Weiss, MD, PhD

獲取全文